Scientific validation of anti-arthritic effect of Kashayams - A polyherbal formulation in collagen induced arthritic rats

被引:10
作者
Aswathy, I. S. [1 ]
Krishnan, Santhi [1 ]
Peter, Jasmine [1 ]
Sabu, Vidya [1 ]
Helen, A. [1 ]
机构
[1] Univ Kerala, Dept Biochem, Thiruvananthapuram 695581, Kerala, India
关键词
Kashayams; Toll-like receptor -4; Anti-Arthritic; Nuclear factor kappa-light-chain-enhancer of activated B cells; Type II collagen; Rheumatoid arthritis; NF-KAPPA-B; RHEUMATOID-ARTHRITIS; INFLAMMATION; CARTILAGE; CYCLOOXYGENASE; EPIDEMIOLOGY; EXTRACT;
D O I
10.1016/j.jaim.2018.02.139
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Toll-like receptor-4 (TLR-4) mediates activation of nuclear factor kappa-light-chainenhancer of activated B cells (NF-kappa B) resulting in induction of proinflammatory genes such as that encoding tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) which played a significant role in cartilage destruction of rheumatoid arthritis (RA). Low risk and better efficacy made herbal drugs more reliable than nonsteroid anti-inflammatory drugs (NSAIDS) in RA treatment. Gugguluthiktam Kashayam (GuK), Punarnavadi Kashayam (PuK) and Balaguluchiadi Kashayam (BgK) are ayurvedic polyherbal formulations prescribed in classical ayurvedic texts Sahasrayogam and Ashtangahridayam as medicines for the treatment of RA. Objective: The objective of the present study was to elucidate the molecular mechanism of anti-arthritic effect of these Kashayams on TLR-4 signal transduction pathway in collagen induced arthritic rats. Material and methods: The wistar rats grouped into group I - Normal, group II- Collagen induced arthritis (CIA), group III- CIA + BgK, group IV- CIA + PuK, group V- CIA + GuK, group VI - CIA + Indomethacin (3 mg/kg b.wt.). Treatment with Kashayam (2 ml/kg b.wt) started after 14 days of primary immunization with type II collagen and continued for a period of 45 days. Material and methods: The wistar rats grouped into group I - Normal, group II- Collagen induced arthritis (CIA), group III- CIA + BgK, group IV- CIA + PuK, group V- CIA + GuK, group VI - CIA + Indomethacin (3 mg/kg b.wt.). Treatment with Kashayam (2 ml/kg b.wt) started after 14 days of primary immunization with type II collagen and continued for a period of 45 days. Results: Arthritis index, C-reactive protein (CRP), rheumatoid factor (RF) and myeloperoxidase (MPO) in serum and protein level of TLR-4, myeloid differentiation factor 88 (MYD88), NF-kappa B, TNF-alpha, IL-1 beta, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 COX-2) and prostaglandin E-2 (PGE-2) in cartilage were significantly elevated in CIA rats. Further, treatment with Kashayams downregulated all these inflammatory mediators hitherto TLR-4-NF-kappa B signal transduction pathway except IL-10, an antiinflammatory cytokine which showed a reverse effect. Conclusion: This molecular mechanism of the investigation confirmed the clinical efficacy of Kashayams in preventing the progression of RA and gave an intuition of the scientific validation of Kashayams, an Ayurvedic classical medicine. (C) 2018 Transdisciplinary University, Bangalore and World Ayurveda Foundation. Publishing Services by Elsevier B.V.
引用
收藏
页码:20 / 27
页数:8
相关论文
共 53 条
[1]   Gypenosides derived from Gynostemma pentaphyllum suppress NO synthesis in murine macrophages by inhibiting iNOS enzymatic activity and attenuating NF-κB-mediated iNOS protein expression [J].
Aktan, F ;
Henness, S ;
Roufogalis, BD ;
Ammit, AJ .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2003, 8 (04) :235-242
[2]   NF-κB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH) [J].
Allport, VC ;
Slater, DM ;
Newton, R ;
Bennett, PR .
MOLECULAR HUMAN REPRODUCTION, 2000, 6 (06) :561-565
[3]   Therapeutics Role of Azadirachta indica (Neem) and Their Active Constituents in Diseases Prevention and Treatment [J].
Alzohairy, Mohammad A. .
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016
[4]  
Axelrod B., 1981, METHODS ENZYMOLOGY, V71, P441, DOI [10.1016/0076-6879(81)71055-3, DOI 10.1016/0076-6879(81)71055-3]
[5]  
Bansod Mangesh S, 2011, INT J PHARM PHARM SC, V3
[6]  
Bijjiga E., 2011, J. Clin. Cell. Immunol, V10, DOI [DOI 10.4172/2155-9899.S1-007, 10.4172/2155-9899.S1-007]
[7]  
Bilecik NA, 2014, INT J CLIN EXP MED, V7, P2258
[8]  
Bishayi Biswadev, 2002, J Toxicol Sci, V27, P139, DOI 10.2131/jts.27.139
[9]   MEASUREMENT OF CUTANEOUS INFLAMMATION - ESTIMATION OF NEUTROPHIL CONTENT WITH AN ENZYME MARKER [J].
BRADLEY, PP ;
PRIEBAT, DA ;
CHRISTENSEN, RD ;
ROTHSTEIN, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1982, 78 (03) :206-209
[10]   Collagen-induced arthritis [J].
Brand, David D. ;
Latham, Kary A. ;
Rosloniec, Edward F. .
NATURE PROTOCOLS, 2007, 2 (05) :1269-1275